Stemline Therapeutics Announces Three ELZONRIS Presentations, Including an Oral Presentation in Myelofibrosis, at Upcoming ASH Meeting

6 Nov 2019 - Yahoo News
NEW YORK, Nov. 06, 2019 -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel.
usx:stml

---

Stemline Therapeutics to Host Conference Call on Third Quarter 2019 Financial Results on November 8, 2019

5 Nov 2019 - Yahoo News
Stemline Therapeutics, Inc. (STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, announced today that the company will host a conference call and webcast on Friday, November 8, 2019 at 8:00 a.m. ET to report its third quarter ...
usx:stml

---

Stemline Therapeutics Inc (STML) Is Burning These Hedge Funds

30 Oct 2019 - Yahoo News
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]
usx:stml

---

Did Changing Sentiment Drive Stemline Therapeutics's (NASDAQ:STML) Share Price Down By 41%?

22 Oct 2019 - Yahoo News
The simplest way to benefit from a rising market is to buy an index fund. While individual stocks can be big winners...
usx:stml

---

Stemline Therapeutics Announces ELZONRIS® Clinical Data Selected for Oral Presentation at the 81st Annual Meeting of the Japanese Society of Hematology

8 Oct 2019 - Yahoo News
NEW YORK, Oct. 08, 2019 -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel.
usx:stml

---

Stemline Therapeutics Recaps Felezonexor (SL-801) Clinical Data Presentation From ESMO 2019 Congress

1 Oct 2019 - Yahoo News
NEW YORK, Oct. 01, 2019 -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel.
usx:stml

---

Stemline Therapeutics Announces Felezonexor (SL-801) Clinical Data to be Featured at Upcoming ESMO 2019 Congress

27 Sep 2019 - Yahoo News
NEW YORK, Sept. 27, 2019 -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel.
usx:stml

---

Stemline Therapeutics to Present at the 2019 Cantor Global Healthcare Conference

26 Sep 2019 - Yahoo News
NEW YORK, Sept. 26, 2019 -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel.
usx:stml

---

Does The Stemline Therapeutics, Inc. (NASDAQ:STML) Share Price Tend To Follow The Market?

19 Sep 2019 - Yahoo News
If you're interested in Stemline Therapeutics, Inc. (NASDAQ:STML), then you might want to consider its beta (a measure...
usx:stml

---

Stemline Therapeutics to Present at the Ladenburg Thalmann 2019 Healthcare Conference

18 Sep 2019 - Yahoo News
NEW YORK, Sept. 18, 2019 -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel.
usx:stml

---